Navigation Links
Early Detection Of Facial Abnormalities in a Fetus

A cleft happens when the tissues of the face fail to fuse during gestation. It is a repairable birth defect. Cleft lip and palate are the most common facial malformation in newborns. It affects about one in 700 babies.//New research shows fetal magnetic resonance imaging may be more accurate at detecting cleft lip and palate than a sonogram.

The detection rates when using sonography for cleft lip and palate are somewhere between 16 percent and 93 percent. Many variables play a role in the ability to see the malformation including amniotic fluid volumes, fetus position, mother’s physical characteristics, and shadows from bones.

Researchers say it is important to detect cleft lip and palate prenatally in order to screen for associated syndromes and chromosome abnormalities. If cleft lip and palate is detected, families can be prepared for the appearance of the baby at the time of the birth. The parents can also be appropriately counseled regarding the expected appearance after surgery is performed, say specialists.

MRI was also looked at as an alternative to Sonography and it was found that fetal MRI allows more detailed and conclusive prenatal evaluation of the upper lip than sonography alone. They also found soft palate defects, which are often difficult to see on sonography, were able to be detected with MRI. This is important because soft palate defects can lead to potential complications after birth.

Thus researchers say that MRI has indeed increased the vigilance in analysis of facial anatomy thereby allowing parents to receive the necessary counseling before the birth of their child.
'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants

Post Your Comments:
(Date:11/27/2009)... low-emission vehicles may reduce future disease b...27 (HealthDay News) -- Encouraging city dwellers t...er much greater public health benefits than increa...s have found. , The study compared the projecte... transport scenarios for London, England, and Delh...
(Date:11/27/2009)... Specialist manufacturers who use medical load ce...ions of dollars by bringing in technology partner ...mbers of pro-active medical manufacturers are call...age of their projects, ensuring that progress will...r potentially outdated technology. , ...
(Date:11/26/2009)...g drug tetrathiomolybdate (TM) has been shown in s...disease, a disease caused by an overload of copper...wn. Very little, however, is known about how the d...led by Northwestern University researchers now has...l structure of TM bound to copper-loaded metalloch...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leading d...day announced the expansion of its services to inc.... Doug Macmillan. , Du...eased to announce that Dr. Doug Macmillan, an expe... additional advanced training seminar. RTDental&r...
(Date:11/25/2009)....,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceutic...ywillhosttwoinvestoreventsinDecember: ,, ASHB....m.ET ,, Principalinvestigatorswilldiscussdat...orrefractorymultiplemyeloma,asfeaturedatthe51stAme...itioninNewOrleans,LA.Theteleconferencewillbeginat9...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...ry Projects, REDWOOD CITY, Calif., Sept. 26 Gene... today that it has obtained,commitments from sever...ly,12.9 million shares of its common stock and war... purchase the,shares and warrants for $1.84 per un...
... and Interdisciplinary Communication With...la., Sept. 26 Eclipsys,Corporation(R) (Nasdaq: E...at Health First, an integrated healthcare delivery...ults include,reduced duplicate documentation, impr...
...s must be very high , , WEDNESDAY, Sept. 2...and acetaminophen (such as Tylenol), taken togethe... This combo produces a byproduct enzyme that,s tox...minophen, the experts added, but also from large d...
...er Breast Cancer Advocates from ...Sept. 26 "Ignite the Promise: Global,Advocate Sum...er activists,from around the world. The Summit wil...ly detection and treatment,options in their countr...
...,President of Ronco Inventions, Inc., has signed a... implement a new international direct sales and,ma...ulletin Board: NNTN).,During his tenure as Preside... remarked, "Tim Dupler has a,proven track record o...
...akes to Take Place at This Year,s Annual C...NAPOLIS, Md., Sept. 26 CBaySystems, a leading,pro..., today announced that,it will be giving away a ne...s to thank the entire HIM community for,helping to...
Other Medicine News:Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes 2Health News:Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes 3Health News:Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes 4Health News:Caffeine Plus Acetaminophen Toxic for Some 2Health News:Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30 2Health News:Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition 2Health News:CBaySystems to Give Away a 2008 Honda Civic at AHIMA 2007 2
(Date:11/27/2009)...LTLAKECITY,Nov.27/PRNewswire-FirstCall/--Booth-364...,apremiersupplierofX-raytubesandflatpaneldigitalim...heRSNAAnnualMeetinginChicago,Ill.fromNovember29-De...chnologyformultiplemodalitiesaswellasspecializedca...llshowcasethelatestX-raytechnologyincluding: ,,...
(Date:11/25/2009)...NOGAPARK,Calif.,Nov.25/PRNewswire/--PraxisElectron...ricanAcademyofFamilyPhysicians,(AAFP)FamilyPractic...provingmedicalquality,healthmaintenance,anddisease...n.Praxisalsoranked#1amongdoctorsindicatingtheirEMR...,Praxisalsorankednumberoneinthecountryinprovidinge...
(Date:11/25/2009)...INCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmas...alcompanycommittedtodiscovering,developingandcomme...dfinancialresultsforthefiscalyearendedSeptember30,...ncash,cashequivalentsandshortterminvestments. ,... ,, Phase2bTrial ,, InlateNovember2009,a...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Scientists Spot Clue to Cancers Aggressiveness 56441 1Lapatinib shows minimal effect against liver cancer 56439 1Lapatinib shows minimal effect against liver cancer 56439 2Lapatinib shows minimal effect against liver cancer 56439 3Team reveals molecular mechanism underlying a form of diabetes 56437 1Team reveals molecular mechanism underlying a form of diabetes 56437 2
...armaceuticals, a privately-held biopharmaceutical ...ollment in the Company,s second pivotal Phase 3 cl... Together with the previously completed first pivo... fully enrolled its planned pivotal Phase 3 studie...e oral therapy currently in development for the tr...
...ut tumor growth and reduced the risk of disease pr... , - Only once-daily oral cancer treatment to dire...ontrols tumor cell division and blood vessel growt...ntial of Afinitor in multiple additional cancers ,...ed today that Afinitor(R) (everolimus) tablets has...
Other Medicine Technology:QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 2Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 4Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 5Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 6Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 7Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 8
PelviSoft® Acellular Collagen BioMesh
High Pure Viral RNA Kit
...s a simple, fast and cost-effective method to puri...s system utilizes guanidine thiocyanate and 2-merc...Nase and denature proteins. Purified viral RNA is ... and RNase protection assays. This system is ideal...
MicroReader 4 Plus
Medicine Products: